Last reviewed · How we verify
NCT03786055: Y4CIPN
Somatic Yoga and Meditation for Cancer Survivors With Pain From Neuropathy
NA trial testing Somatic Yoga and Meditation (SYM) in Cancer Survivor in 18 participants. Completed in 31 July 2019.
31 July 2019
Quick facts
| Lead sponsor | Stockton University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 18 |
| Start date | 4 June 2018 |
| Primary completion | 31 July 2019 |
| Estimated completion | 31 July 2019 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Somatic Yoga and Meditation (SYM)
Conditions studied
- Cancer Survivor — all drugs for Cancer Survivor →
- Pain — all drugs for Pain →
- Chemotherapy Induced Peripheral Neuropathy — all drugs for Chemotherapy Induced Peripheral Neuropathy →
- Function — all drugs for Function →
Sponsor
Stockton University
Who can join
18 and older, any sex, with Cancer Survivor or Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Chemotherapy-induced peripheral neuropathy syndrome (CIPN) causes significant pain in hands and feet and is an adverse effect of treatment. Few non-pharmacological interventions have been tested and individuals experience CIPN symptoms years after treatment. This is the first study to explore a somatic yoga and meditation (SYM) intervention on functional outcomes and quality of life in cancer survivors.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of Somatic Yoga and Meditation on Fall Risk, Function, and Quality of Life for Chemotherapy-Induced Peripheral Neuropathy Syndrome in Cancer Survivors.
Galantino ML, Tiger R, Brooks J, Jang S, et al · · 2019 · cited 24× · PMID 31131640 · DOI 10.1177/1534735419850627
Verify or expand the search:
- PubMed search for NCT03786055
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer Survivor
Currently open trials in the same condition.
- NCT06894849 — Text -Based Depression Screening Among Cancer Survivors · NA · recruiting
- NCT06868524 — Leading Healthy Eating and Activity Promotion Program · NA · recruiting
- NCT06574009 — Better Options for Chronic Cancer Pain · Phase 4 · recruiting
- NCT06939322 — LOG-I - Impact Study of LOG-AFTER Software on Long-term Monitoring of Former Patients (LOG-I - LOG-Impact Study) · NA · recruiting
- NCT06814977 — An Acupuncture Study for Cancer Survivors With Joint Pain · NA · recruiting
Other Stockton University trials
Trials by the same sponsor.
- NCT03211689 — The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03786055 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stockton University
- Last refreshed: 15 August 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03786055.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing